The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×

Brain disease research has historically focused on abnormalities of neurotransmitter release at synapses. However, modern neuroscience has uncovered numerous intracellular signaling pathways affecting synapse development and function that likely play roles in diseases of mood and cognition. Sensory, cognitive, and motor experiences play important roles in shaping neuronal circuitry by affecting the development and maturation of synaptic connections. Environmental stimulation and resultant neuronal activity trigger the influx of calcium into neurons through L-type voltage-gated calcium channels or through N -methyl- d -aspartic acid (NMDA)- or AMPA-gated ion channels. The present image depicts the signaling pathways induced by neuronal activity driven calcium influx that lead to the transcription of new gene products. More than 300 genes are transcribed in response to increased intracellular calcium, and, remarkably, each gene has a unique time course and magnitude of induction. These newly transcribed genes play important roles in many aspects of nervous system development through the regulation of neuronal survival, dendritic growth, synapse formation, and synaptic refinement. Activity-dependent transcription also plays a role later in development by modulating synaptic plasticity, allowing for learning and the formation of new memories. Interestingly, recent research in this area has revealed that the mutation of a number of activity-regulated transcripts and the proteins that regulate their transcription can result in diseases of human cognition. For example, Rett syndrome, Rubinstein-Taybi syndrome, Coffin-Lowry syndrome, and some forms of autism are caused by mutations of components of the activity-dependent gene transcription program. It may be that milder diseases of cognition, such as epilepsy and autism, arise from mutations in the regulatory regions that control the expression of activity-regulated genes, while mutations that disrupt the coding region of genes may cause more severe cognitive phenotypes, such as mental retardation. As more components of the signaling networks that control the transcription of activity-dependent genes are identified, it is remarkable to note the significant degree of overlap between genes that regulate activity-dependent transcription and genes that are mutated in human cognitive disorders. This observation suggests that a thorough comparison of the genes involved in cognitive disorders and components of the activity-regulated gene network governing synapse development and function will increase our understanding of disorders of human cognition.

Figure 1.

Figure 1. Image modified/adapted with permission from Greer PL, Greenberg ME, “From Synapse to Nucleus: Calcium-Dependent Gene Transcription in the Control of Synapse Development and Function” Neuron; 59:846–860. Copyright © Elsevier 2008.

Address reprint requests to Dr. Tamminga, UT Southwestern Medical Center, Department of Psychiatry, 5323 Harry Hines Blvd., #NE5.110, Dallas, TX 75390-9070; [email protected] (e-mail). Image accepted for publication November 2008 (doi: 10.1176/appi.ajp.2008.08111731).